Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Claudine, Sohn"'
Autor:
Claudine Sohn, Denis Caillot, Intergroupe Francophone du Myelome, Valentine Richez, Lauriane Clement-Filliatre, Hervé Avet-Loiseau, Lionel Karlin, Karim Belhadj, Philippe Collet, Mourad Tiab, Philippe Moreau, Mamoun Dib, Sabine Brechignac, Jean Fontan, Borane Slama, Cyrille Hulin, François Lifermann, Margaret Macro, Thierry Facon, Mohamad Mohty, Philippe Rey, Hélène Demarquette, Aurore Perrot, Jill Corre, Clara Mariette, Anne-Marie Stoppa, Xavier Leleu, Frédérique Orsini-Piocelle, Laurent Voillat, Jean-Pierre Marolleau
Publikováno v:
Leukemia. 35:3600-3603
Autor:
Jill, Corre, Aurore, Perrot, Cyrille, Hulin, Denis, Caillot, Anne-Marie, Stoppa, Thierry, Facon, Xavier, Leleu, Mamoun, Dib, Lionel, Karlin, Philippe, Moreau, Mohamad, Mohty, Clara, Mariette, Jean, Fontan, Jean-Pierre, Marolleau, Hélène, Demarquette, Borane, Slama, Laurent, Voillat, Margaret, Macro, Frédérique, Orsini-Piocelle, Sabine, Brechignac, Philippe, Rey, Philippe, Collet, Mourad, Tiab, Karim, Belhadj, François, Lifermann, Lauriane, Clement-Filliatre, Claudine, Sohn, Valentine, Richez, Hervé, Avet-Loiseau
Publikováno v:
Leukemia. 35(12)
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma
Autor:
Philippe Moreau, Philippe Rodon, Marie-Lorraine Chretien, Hervé Avet-Loiseau, Olivier Decaux, Cyrille Hulin, Sabine Brechignac, Hélène Demarquette, Xavier Leleu, Michel Attal, Bruno Royer, Laurent Voillat, Philippe Collet, Jill Corre, Aurore Perrot, Margaret Macro, Frédérique Orsini-Piocelle, François Lifermann, Karim Belhadj, Thierry Facon, Arnaud Jaccard, Valérie Lauwers-Cances, Stephane Minvielle, Mohamad Mohty, Elodie Tournay, Valentine Richez, Mamoun Dib, Jean Fontan, Claudine Sohn
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (19), pp.1657-1665. ⟨10.1200/JCO.18.00776⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (19), pp.1657-1665. ⟨10.1200/JCO.18.00776⟩
PURPOSE The wide heterogeneity in multiple myeloma (MM) outcome is driven mainly by cytogenetic abnormalities. The current definition of high-risk profile is restrictive and oversimplified. To adapt MM treatment to risk, we need to better define a cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05516ecd273afb9c27aa3afbe29c2a69
https://www.hal.inserm.fr/inserm-02348535
https://www.hal.inserm.fr/inserm-02348535
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes
Autor:
Ismahane Bekhouche, Jean-Albert Gastaut, Marie-Joelle Mozziconacci, Anne Etienne, Max Chaffanet, Sylviane Olschwang, Danielle Sainty, Claudine Sohn, Nadine Carbuccia, Daniel Birnbaum, José Adélaïde, Virginie Rémy
Publikováno v:
Cancer Genetics and Cytogenetics
Cancer Genetics and Cytogenetics, 2007, 176 (1), pp.80-88. ⟨10.1016/j.cancergencyto.2007.03.009⟩
Cancer Genetics and Cytogenetics, 2007, 176 (1), pp.80-88. ⟨10.1016/j.cancergencyto.2007.03.009⟩
International audience; We report two cases of translocation associated with deletion on derivative chromosomes in atypical myeloproliferative disorder (MPD). In a MPD with t(3;12)(q29;q14), the rearrangement targeted the HMGA2 locus at 12q14 and del
Autor:
Jill Corre, Denis Caillot, Thierry Facon, Nicolas Daguindau, Philippe Rodon, Olivier Allangba, Laurence Lodé, Marie-Véronique Joubert, Gerald Marit, Mamoun Dib, Benjamin Hebraud, Claudine Sohn, Laurence Legros, Brigitte Kolb, Michel Maigre, Pascal Lenain, Laurent Garderet, Olivier Fitoussi, Eric Voog, Xavier Leleu, Marc Wetterwald, Lionel Karlin, Bruno Royer, Anne-Marie Stoppa, Laurent Voillat, Michel Attal, Cyrille Hulin, Nadine Boullanger, Philippe Moreau, Hervé Avet-Loiseau
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2013, 19 (17), pp.4634-4637. ⟨10.1158/1078-0432.CCR-12-3866⟩
Clinical Cancer Research, American Association for Cancer Research, 2013, 19 (17), pp.4634-4637. ⟨10.1158/1078-0432.CCR-12-3866⟩
Purpose: Although the translocation t(4;14) is supposed to be a primary event in multiple myeloma, we have been surprised to observe that in large relapse series of patients, the t(4;14) can be observed only in subpopulations of plasma cells, in cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1b27dc7fe5c1e0f5aa7025f3ed9bea
https://hal.archives-ouvertes.fr/hal-00868839
https://hal.archives-ouvertes.fr/hal-00868839
Autor:
Benjamin Hebraud, Cecile Fohrer, M. Attal, Valérie Lauwers-Cances, François Guilhot, Jill Corre, T. Lamy, Lionel Karlin, Hervé Avet-Loiseau, Laurent Garderet, Murielle Roussel, Catherine Sebban, C Gentil, Thierry Facon, Christophe Fruchart, Denis Caillot, Frédérique Orsini-Piocelle, Mamoun Dib, Jean Fontan, Jérôme Jaubert, Stoppa Am, Brigitte Pegourie, Gérard Lepeu, Philippe Moreau, Xavier Leleu, Claudine Sohn, C. Hulin, Gerald Marit, Sabine Brechignac, Margaret Macro
Publikováno v:
Leukemia. 28(3)
Deletions of the 1p region appear as a pejorative prognostic factor in multiple myeloma patients (especially 1p22 and 1p32 deletions) but there is a lack of data on the real impact of 1p abnormalities on an important and homogeneous group of patients
Autor:
Bruno Audhuy, Gérard Lepeu, Antoine Thyss, Claudine Sohn, Regis Kaphan, Christophe Fruchart, Jocelyn Gal, Diane Coso, Serge Bologna, Gomez Codina, Mariano Provencio, Frederic Peyrade
Publikováno v:
Journal of Clinical Oncology. 30:6633-6633
6633 Background: IT-Y90was approved in follicular lymphoma, and some data indicates that it could be used in DLBCL. It has been reported that early TEP-TDM negativity is associated with a longer survival in DLBCL, which suggest that these patients co